Product Information
THIORIDAZINE 25 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.5713 per EA under NDC 00378061401. Its NADAC has been published 550 times since Nov 28, 2013.
FDA first approved this application on Mar 15, 1983.
Strength
25 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378061401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
THIORIDAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088004FDA Approved
3/15/1983
On Market Since
3/15/1983
Pharmacological Classes
Price Statistics
The NADAC for THIORIDAZINE 25 MG TABLET has been published 550 times since Nov 28, 2013, and over the history we have for it it has risen 144.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5713 per EA |
|---|---|
| All-time high | $0.7347 (Dec 14, 2016) |
| All-time low | $0.2333 (Nov 28, 2013) |
| 52-week high | $0.5786 |
| 52-week low | $0.5569 |
| Median price | $0.5761 |
| Average price | $0.5489 |
| Largest weekly change | +76.5% (Jun 25, 2014) |
| Weeks tracked | 550 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
thioridazine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of THIORIDAZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for THIORIDAZINE 25 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.5713 per EA (NDC 00378061401), effective Sep 30, 2026.
How has the price of THIORIDAZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for THIORIDAZINE 25 MG TABLET has risen 144.9%. It has been tracked across 550 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for THIORIDAZINE 25 MG TABLET?
Since Nov 28, 2013, the NADAC for THIORIDAZINE 25 MG TABLET has ranged from a low of $0.2333 (Nov 28, 2013) to a high of $0.7347 (Dec 14, 2016), with a median of $0.5761 per EA.
Are there cheaper alternatives to THIORIDAZINE 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as THIORIDAZINE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures THIORIDAZINE 25 MG TABLET?
THIORIDAZINE 25 MG TABLET (NDC 00378061401) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.